US Stock MarketDetailed Quotes

VBIV VBI Vaccines

Watchlist

0.590
+0.007+1.27%

Close May 3 16:00 ET

0.599
+0.009+1.44%

Post 17:21 ET

16.92MMarket Cap-97P/E (TTM)

VBI Vaccines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

17.39%-60.88M

36.70%-12.06M

53.92%-7.96M

-10.09%-19.21M

-8.69%-21.66M

-84.66%-73.7M

-2.86%-19.05M

-328.64%-17.27M

-62.81%-17.45M

-199.89%-19.93M

Net income from continuing operations

18.06%-92.84M

99.94%-13K

18.90%-20.44M

2.34%-44.63M

-30.57%-27.75M

-62.43%-113.3M

-12.55%-21.14M

-59.08%-25.21M

-161.50%-45.7M

-20.44%-21.25M

Operating gains losses

-76.07%6.61M

-1,483.63%-15.28M

277.55%8.48M

-70.42%6.52M

60.46%6.9M

5,667.94%27.62M

---965K

--2.25M

19,404.42%22.04M

2,504.24%4.3M

Depreciation and amortization

-3.44%1.99M

-8.85%474K

-5.32%498K

-5.90%510K

7.40%508K

12.32%2.06M

10.87%520K

18.20%526K

14.11%542K

6.05%473K

Other non cash items

31.94%475K

-71.77%35K

14.36%-501K

14.60%471K

14.63%470K

-81.36%360K

-45.85%124K

-354.35%-585K

70.54%411K

-66.69%410K

Change In working capital

-664.84%-10.05M

-56.58%132K

-142.46%-972K

-293.47%-5.16M

38.35%-4.05M

-107.83%-1.31M

119.12%304K

-73.24%2.29M

-8.32%2.67M

-195.26%-6.57M

-Change in receivables

213.79%99K

807.50%363K

-4,057.14%-277K

595.00%198K

-96.81%-185K

-226.09%-87K

37.93%40K

-87.27%7K

-147.06%-40K

6.00%-94K

-Change in inventory

34.66%-3.72M

-34.11%-692K

73.08%-794K

-239.50%-1.63M

65.65%-599K

-1,009.16%-5.69M

-177.59%-516K

-379.51%-2.95M

-37.82%-481K

-714.95%-1.74M

-Change in prepaid assets

-5.56%17K

56.71%666K

-21.23%-1.29M

69.82%754K

-156.46%-118K

102.29%18K

-38.41%425K

31.61%-1.06M

207.51%444K

-57.00%209K

-Change in payables and accrued expense

-174.80%-6.65M

-156.64%-729K

-103.12%-209K

-284.02%-2.51M

-598.04%-3.2M

2,398.03%8.89M

271.97%1.29M

218.04%6.7M

7,923.53%1.36M

78.29%-459K

-Change in other current assets

472.65%5.79M

247.71%2.55M

-162.47%-1.23M

102.56%26K

668.33%4.45M

-125.71%-1.55M

-211.67%-1.72M

-17.13%1.97M

-173.06%-1.02M

-206.68%-783K

-Change in other current liabilities

-310.41%-11.94M

-335.03%-1.89M

-54.01%-3.65M

-185.20%-2M

-19.40%-4.41M

-124.39%-2.91M

116.84%805K

-137.88%-2.37M

4.27%2.34M

-144.95%-3.69M

-Change in other working capital

39,625.00%6.36M

-821.43%-129K

58,918.18%6.47M

-92.31%4K

200.00%11K

104.88%16K

83.33%-14K

84.06%-11K

172.22%52K

89.32%-11K

Cash from discontinued investing activities

Operating cash flow

17.39%-60.88M

36.70%-12.06M

53.92%-7.96M

-10.09%-19.21M

-8.69%-21.66M

-84.66%-73.7M

-2.86%-19.05M

-328.64%-17.27M

-62.81%-17.45M

-199.89%-19.93M

Investing cash flow

Cash flow from continuing investing activities

80.04%-867K

88.29%-170K

91.31%-113K

95.36%-50K

-3.69%-534K

-118.76%-4.34M

-138.03%-1.45M

-205.88%-1.3M

-104.35%-1.08M

7.37%-515K

Net PPE purchase and sale

80.04%-867K

88.29%-170K

91.31%-113K

95.36%-50K

-3.69%-534K

-117.74%-4.34M

-138.03%-1.45M

-205.88%-1.3M

-166.58%-1.08M

7.37%-515K

Cash from discontinued investing activities

Investing cash flow

80.04%-867K

88.29%-170K

91.31%-113K

95.36%-50K

-3.69%-534K

-118.76%-4.34M

-138.03%-1.45M

-205.88%-1.3M

-104.35%-1.08M

7.37%-515K

Financing cash flow

Cash flow from continuing financing activities

16.71%22.7M

272K

15.38%22.43M

-56.09%19.45M

175.51%19.44M

-99.94%12K

Net issuance payments of debt

--0

----

66.67%20M

--0

----

Net common stock issuance

202,175.00%24.27M

2,941.67%365K

199,333.33%23.91M

--0

-99.96%12K

-99.60%12K

-100.17%-12K

--0

-99.95%12K

Net other financing activities

-179.75%-1.58M

---93K

----

48.30%-563K

--0

----

Cash from discontinued financing activities

Financing cash flow

16.71%22.7M

--272K

15.38%22.43M

--0

-56.09%19.45M

--0

175.51%19.44M

--0

-99.94%12K

Net cash flow

Beginning cash position

-48.54%62.63M

-57.57%35.45M

-74.71%20.84M

-60.14%40.39M

-48.54%62.63M

29.70%121.69M

-39.22%83.55M

-38.96%82.41M

-6.37%101.34M

29.70%121.69M

Current changes in cash

33.35%-39.05M

41.68%-11.96M

1,563.15%14.35M

-3.96%-19.26M

-8.63%-22.19M

-312.74%-58.59M

-26.27%-20.5M

-66.81%863K

-169.26%-18.53M

-241.63%-20.43M

Effect of exchange rate changes

122.74%108K

143.97%186K

-4.40%261K

26.26%-292K

-166.20%-47K

-244.82%-475K

-192.36%-423K

273.89%273K

-892.00%-396K

408.70%71K

End cash Position

-62.18%23.69M

-57.57%35.45M

-74.71%20.84M

-60.14%40.39M

-48.54%62.63M

-39.22%83.55M

-38.96%82.41M

-6.37%101.34M

Free cash flow

20.87%-61.75M

40.35%-12.23M

56.54%-8.07M

-3.96%-19.26M

-8.56%-22.19M

-86.24%-78.04M

-7.17%-20.5M

-316.92%-18.57M

-66.58%-18.53M

-183.89%-20.44M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	17.39%-60.88M	36.70%-12.06M	53.92%-7.96M	-10.09%-19.21M	-8.69%-21.66M	-84.66%-73.7M	-2.86%-19.05M	-328.64%-17.27M	-62.81%-17.45M	-199.89%-19.93M
Net income from continuing operations	18.06%-92.84M	99.94%-13K	18.90%-20.44M	2.34%-44.63M	-30.57%-27.75M	-62.43%-113.3M	-12.55%-21.14M	-59.08%-25.21M	-161.50%-45.7M	-20.44%-21.25M
Operating gains losses	-76.07%6.61M	-1,483.63%-15.28M	277.55%8.48M	-70.42%6.52M	60.46%6.9M	5,667.94%27.62M	---965K	--2.25M	19,404.42%22.04M	2,504.24%4.3M
Depreciation and amortization	-3.44%1.99M	-8.85%474K	-5.32%498K	-5.90%510K	7.40%508K	12.32%2.06M	10.87%520K	18.20%526K	14.11%542K	6.05%473K
Other non cash items	31.94%475K	-71.77%35K	14.36%-501K	14.60%471K	14.63%470K	-81.36%360K	-45.85%124K	-354.35%-585K	70.54%411K	-66.69%410K
Change In working capital	-664.84%-10.05M	-56.58%132K	-142.46%-972K	-293.47%-5.16M	38.35%-4.05M	-107.83%-1.31M	119.12%304K	-73.24%2.29M	-8.32%2.67M	-195.26%-6.57M
-Change in receivables	213.79%99K	807.50%363K	-4,057.14%-277K	595.00%198K	-96.81%-185K	-226.09%-87K	37.93%40K	-87.27%7K	-147.06%-40K	6.00%-94K
-Change in inventory	34.66%-3.72M	-34.11%-692K	73.08%-794K	-239.50%-1.63M	65.65%-599K	-1,009.16%-5.69M	-177.59%-516K	-379.51%-2.95M	-37.82%-481K	-714.95%-1.74M
-Change in prepaid assets	-5.56%17K	56.71%666K	-21.23%-1.29M	69.82%754K	-156.46%-118K	102.29%18K	-38.41%425K	31.61%-1.06M	207.51%444K	-57.00%209K
-Change in payables and accrued expense	-174.80%-6.65M	-156.64%-729K	-103.12%-209K	-284.02%-2.51M	-598.04%-3.2M	2,398.03%8.89M	271.97%1.29M	218.04%6.7M	7,923.53%1.36M	78.29%-459K
-Change in other current assets	472.65%5.79M	247.71%2.55M	-162.47%-1.23M	102.56%26K	668.33%4.45M	-125.71%-1.55M	-211.67%-1.72M	-17.13%1.97M	-173.06%-1.02M	-206.68%-783K
-Change in other current liabilities	-310.41%-11.94M	-335.03%-1.89M	-54.01%-3.65M	-185.20%-2M	-19.40%-4.41M	-124.39%-2.91M	116.84%805K	-137.88%-2.37M	4.27%2.34M	-144.95%-3.69M
-Change in other working capital	39,625.00%6.36M	-821.43%-129K	58,918.18%6.47M	-92.31%4K	200.00%11K	104.88%16K	83.33%-14K	84.06%-11K	172.22%52K	89.32%-11K
Cash from discontinued investing activities
Operating cash flow	17.39%-60.88M	36.70%-12.06M	53.92%-7.96M	-10.09%-19.21M	-8.69%-21.66M	-84.66%-73.7M	-2.86%-19.05M	-328.64%-17.27M	-62.81%-17.45M	-199.89%-19.93M
Investing cash flow
Cash flow from continuing investing activities	80.04%-867K	88.29%-170K	91.31%-113K	95.36%-50K	-3.69%-534K	-118.76%-4.34M	-138.03%-1.45M	-205.88%-1.3M	-104.35%-1.08M	7.37%-515K
Net PPE purchase and sale	80.04%-867K	88.29%-170K	91.31%-113K	95.36%-50K	-3.69%-534K	-117.74%-4.34M	-138.03%-1.45M	-205.88%-1.3M	-166.58%-1.08M	7.37%-515K
Cash from discontinued investing activities
Investing cash flow	80.04%-867K	88.29%-170K	91.31%-113K	95.36%-50K	-3.69%-534K	-118.76%-4.34M	-138.03%-1.45M	-205.88%-1.3M	-104.35%-1.08M	7.37%-515K
Financing cash flow
Cash flow from continuing financing activities	16.71%22.7M	272K	15.38%22.43M	0	0	-56.09%19.45M	0	175.51%19.44M	0	-99.94%12K
Net issuance payments of debt	--0	--0	----	----	----	66.67%20M	--0	----	----	----
Net common stock issuance	202,175.00%24.27M	2,941.67%365K	199,333.33%23.91M	--0	--0	-99.96%12K	-99.60%12K	-100.17%-12K	--0	-99.95%12K
Net other financing activities	-179.75%-1.58M	---93K	----	----	----	48.30%-563K	--0	----	----	----
Cash from discontinued financing activities
Financing cash flow	16.71%22.7M	--272K	15.38%22.43M	--0	--0	-56.09%19.45M	--0	175.51%19.44M	--0	-99.94%12K
Net cash flow
Beginning cash position	-48.54%62.63M	-57.57%35.45M	-74.71%20.84M	-60.14%40.39M	-48.54%62.63M	29.70%121.69M	-39.22%83.55M	-38.96%82.41M	-6.37%101.34M	29.70%121.69M
Current changes in cash	33.35%-39.05M	41.68%-11.96M	1,563.15%14.35M	-3.96%-19.26M	-8.63%-22.19M	-312.74%-58.59M	-26.27%-20.5M	-66.81%863K	-169.26%-18.53M	-241.63%-20.43M
Effect of exchange rate changes	122.74%108K	143.97%186K	-4.40%261K	26.26%-292K	-166.20%-47K	-244.82%-475K	-192.36%-423K	273.89%273K	-892.00%-396K	408.70%71K
End cash Position	-62.18%23.69M	-62.18%23.69M	-57.57%35.45M	-74.71%20.84M	-60.14%40.39M	-48.54%62.63M	-48.54%62.63M	-39.22%83.55M	-38.96%82.41M	-6.37%101.34M
Free cash flow	20.87%-61.75M	40.35%-12.23M	56.54%-8.07M	-3.96%-19.26M	-8.56%-22.19M	-86.24%-78.04M	-7.17%-20.5M	-316.92%-18.57M	-66.58%-18.53M	-183.89%-20.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall